Imvax, Inc.
Philadelphia, Pennsylvania, United States
Raul Perez-Olle, MD, PhD. SVP, Head of Clinical Development and Medical Affairs, Imvax, Inc.
Raul is a physician-scientist with two decades of oncology experience in pharma and biotech, working across multiple solid tumor indications and liquid malignancies, as well as multiple therapeutic modalities, including chemotherapeutic agents, small molecules, antibodies, bispecific antibodies, antibody-drug conjugates, and cellular therapies. He has been involved across the lifecycle of multiple drugs, from IND submission to approval and commercialization. In addition to his role as Head of Clinical Development and Medical Affairs, he is the lead for Imvax’s most advanced program, IGV-001, and has overall accountability for the cross-functional product development team. IGV-001 is currently being evaluated in a Phase 2b clinical trial in newly diagnosed glioblastoma patients.
